HHS plans to rescind a midnight regulation by the Trump administration that makes health centers pass 340b discounts for insulin and epinephrine to patients, according to a proposal being reviewed by the White House budget office. The title of the proposed rule is “Rescission of the Final Rule ‘Implementation of Executive Order on Access to Affordable Life-Saving Medications.’” The executive order was one of four that President Donald Trump signed in September to curb drug prices, though it’s considered the...